Baird Upgrades Robbins & Myers (RBN) to Outperform
Baird upgrades Robbins & Myers (NYSE: RBN) from Neutral to Outperform. Price target increased to $27 from $21.
To see more analyst ratings on RBN Click Here.
Robbins & Myers, Inc., together with its subsidiaries, supplies engineered equipment and systems for various applications in energy, industrial, chemical, and pharmaceutical markets worldwide.
Related Categories
UpgradesStocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
